Tags » RESEARCH & STUDIES
An FDA Approved Generic Form of Copaxone® (Glatiramer Acetate) For Relapsing MS Called Glatopa™ Is Launched In the U.S.
A generic equivalent of daily Copaxone® (glatiramer acetate, 20 mg), called “Glatopa”™ (Sandoz, a Novartis company, developed in collaboration with Momenta Pharmaceuticals) that was approved by the U.S. 1,747 more words
Reflections From Part 2 Of The Cochlear Implant Music Study PLUS What My Next Study May Be And An Update On The AquaCase!
Researchers in Boston have effectively grown a rodent appendage that may reform the capacity of specialists to perform entire appendage transplants. As of now, the method known as decel/recel has been utilized to make kidneys, lungs, and hearts in a petri dish, and now specialists accept that bigger organs are in our grasp also. 456 more words
Study Uncovers Gene Variation Linked to Response to MS Therapy; May Open Up New Treatment Approaches
Collaborating researchers in the U.S. and Italy have uncovered a gene variant that appears to influence whether a person responds well to interferon beta, a commonly used therapy for relapsing forms of MS. 477 more words